Robert Radloff (MBA), founder of Curedatis, studied technical biology at the University of Stuttgart (Germany) with a focus on molecular biology and bioinformatics. Robert has more than 8 years’ pharmaceutical and medical device industry experience as a senior clinical research associate, product manager and medical writer in various therapeutic areas. The last year Robert has created a prototype software solution; Curedatis. Curedatis is a medical language processing and "knowledge as a service" startup. Its goal is to realize the existing potential of big data within scientific publication with the use of smart workflows together with machine learning and natural language processing (NLP).
